Pierre Regenass
Freiburg, BW 79104, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Structure-Guided Design of a KMT9 Inhibitor Prodrug with Cellular Activity.
Journal: Journal of medicinal chemistry
Published: June 17, 2025
A novel pan-selective bromodomain inhibitor for epigenetic drug design.
Journal: European journal of medicinal chemistry
Published: December 01, 2022
Structure-Based Design, Docking and Binding Free Energy Calculations of A366 Derivatives as Spindlin1 Inhibitors.
Journal: International journal of molecular sciences
Published: May 05, 2021
4-Acyl Pyrroles as Dual BET-BRD7/9 Bromodomain Inhibitors Address BETi Insensitive Human Cancer Cell Lines.
Journal: Journal of medicinal chemistry
Published: December 04, 2020
Discovery of a Locally and Orally Active CXCL12 Neutraligand (LIT-927) with Anti-inflammatory Effect in a Murine Model of Allergic Airway Hypereosinophilia.
Journal: Journal of medicinal chemistry
Published: August 15, 2018
Beyond the BET Family: Targeting CBP/p300 with 4-Acyl Pyrroles.
Journal: Angewandte Chemie (International ed. in English)
Published: May 30, 2017
A step-economical multicomponent synthesis of 3D-shaped aza-diketopiperazines and their drug-like chemical space analysis.
Journal: Organic & biomolecular chemistry
Published: October 11, 2016
Convenient Access to Fluorescent Probes by Chemoselective Acylation of Hydrazinopeptides: Application to the Synthesis of the First Far-Red Ligand for Apelin Receptor Imaging.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: August 08, 2015
Diastereoselective synthesis of novel aza-diketopiperazines via a domino cyclohydrocarbonylation/addition process.
Journal: Chemical communications (Cambridge, England)
Published: July 15, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026